• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AZIYO BIOLOGICS INC. CORMATRIX ECM FOR CARDIAC TISSUE REPAIR; PATCH, PLEDGET, INTRACARDIAC - DXZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AZIYO BIOLOGICS INC. CORMATRIX ECM FOR CARDIAC TISSUE REPAIR; PATCH, PLEDGET, INTRACARDIAC - DXZ Back to Search Results
Device Problems Use of Device Problem (1670); Improper or Incorrect Procedure or Method (2017)
Patient Problem Unspecified Infection (1930)
Event Type  Death  
Manufacturer Narrative
Manufacturing review of the cormatrix ecm for cardiac tissue repair device history record could not be completed as the lot/serial number was not provided.Information cited in the article states that ".Ecm patch material is expensive and the availability may be limited.We have used this material in our patient population by carefully cutting the new patch, as supplied, into 10 equal pieces at the time of the first use, and then resterilizing the remaining pieces for use in subsequent patient.During our re-sterilization procedure, we took precautions to sterilize it properly and adequately.We did not notice any infections that we believed could be attributed to this cost saving strategy." although the exact cause of the reported issues cannot be conclusively determined, this event infection (systemic) which ultimately resulted in a patient death is identified in the instructions for use provided with the proxicor (cormatrix ecm) for cardiac tissue repair.Further the provided instructions for use (art-20706a) state under warnings and precautions that "for single patient use only.Do not reuse, reprocess or resterilize.Reuse, reprocessing or resterilization will compromise the structural integrity of the device and/or lead to device failure which, in turn, may result in patient injury, illness or death".Individual device pouch, display envelope or carton labels display the fda/iso compliant symbols for do not reuse and do not resterilize.Should aziyo receive any additional details related to this event, a supplemental report will be filed.
 
Event Description
As part of the post market surveillance process, this retrospective single center study report published in the world journal of pediatric and congenital heart surgery titled "preliminary experience with the use of an extracellular matrix to augment the native pulmonary valve during repair of tetrology of fallot" was reviewed.This article summarizes the results of fifty-two (52) patients who underwent surgery for right ventricular outflow tract (rvot) reconstruction and pulmonary valve augmentation during tetrology of fallot requiring a transannular incision.Patients were treated between march 2013 and december 2015 using the cormatrix (now aziyo biologics) extracellular matrix material (model # / lot #: unknown), but likely cormatrix ecm for cardiac tissue repair (now proxicor for cardiac tissue repair).This report is focused patient #2 of 2 patients experiencing systemic infections in the late postoperative period unrelated to the use of the cormatrix patch material and died.The patient was operated on emergency basis while on mechanical ventilator support because of cyanotic spells and developed low cardiac output in the setting of lung infections.Blood cultures were negative and no evidence of infection related to the use of the ecm patch material.The valve demonstrated good function without significant regurgitation.Attempts to contact the corresponding author have been provided minimal additional information regarding specific product used and corresponding lot numbers.Should any additional information be received a follow-up report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CORMATRIX ECM FOR CARDIAC TISSUE REPAIR
Type of Device
PATCH, PLEDGET, INTRACARDIAC - DXZ
Manufacturer (Section D)
AZIYO BIOLOGICS INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer (Section G)
AZIYO BIOLOGICS INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer Contact
michael hennick
1100 old ellis road
ste 1200
roswell, GA 30076
4705144023
MDR Report Key10865279
MDR Text Key217067200
Report Number3005619880-2020-00071
Device Sequence Number1
Product Code DXZ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K063349
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 11/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/18/2020
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/08/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-